Review
Open access
Jul 2026
Efficacy and Safety of SGLT-2 Inhibitors in Patients with Uncontrolled or Resistant Hypertension: A Pilot Meta-Analysis of Randomized Clinical Trials.
SGLT-2 inhibitors provide a modest incremental benefit in lowering office systolic blood pressure for patients with uncontrolled or resistant hypertension on multidrug regimens with an overall acceptable safety profile.
Omer Mohammed, Sun Hyeok Kim, A. Karthikeyan et al.
· High Blood Pressure & Cardio... · 0 citations